Apimeds Pharmaceuticals US, Inc. Share Price
AMEX: APUSApimeds Pharmaceuticals US, Inc. Stock Performance
Open $3.92 | Prev. Close $4.92 | Circuit Range N/A |
Day Range $3.92 - $3.92 | Year Range $0.62 - $8.15 | Volume 4,933 |
Average Traded $3.92 |
Apimeds Pharmaceuticals US, Inc. Share Price Today
As of 29 August 2026, Apimeds Pharmaceuticals US, Inc.'s share price is $3.92. The stock opened at $3.92, compared to its previous close of $4.92. During today's trading session, Apimeds Pharmaceuticals US, Inc.'s share price traded between $3.92 and $3.92, with an average price of $3.92. Over the past 52 weeks, the stock has recorded a high of $8.15 and a low of $0.62. In terms of performance, Apimeds Pharmaceuticals US, Inc.'s share price has risen by 212.35% over the last six months and is up 115.38% on a year-on-year basis.
Apimeds Pharmaceuticals US, Inc. Share Price Chart
Apimeds Pharmaceuticals US, Inc. Quarterly Profit & Loss
All figures in USD
About Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey.
Apimeds Pharmaceuticals US, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.94 | $4.92 | -15.32% |
Jul 2026 | $0.89 | $5.81 | +583.53% |
Jun 2026 | $1.26 | $0.85 | -40.97% |
May 2026 | $5.77 | $1.44 | -15.79% |
Apr 2026 | $1.71 | $1.71 | -1.16% |
Mar 2026 | $1.43 | $1.73 | +37.85% |
Feb 2026 | $1.94 | $1.25 | -33.60% |
Jan 2026 | $1.73 | $1.89 | +2.72% |
Dec 2025 | $3.20 | $1.84 | -35.44% |
Nov 2025 | $2.18 | $2.85 | +29.55% |
Oct 2025 | $1.80 | $2.20 | +22.56% |
Sep 2025 | $1.84 | $1.79 | -1.37% |